Chargement en cours...
Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets.
Interventions to extend lifespan and improve health with increasing age would have significant impact on a growing aged population. There are now several pharmaceutical interventions that extend lifespan in laboratory rodent models with rapamycin, an inhibitor of mechanistic target of rapamycin (mTO...
Enregistré dans:
| Publié dans: | Am J Primatol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415526/ https://ncbi.nlm.nih.gov/pubmed/30311681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajp.22927 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|